STEROCLEAR HAYFEVER (AFT Pharmaceuticals Pty Ltd)
Product name
STEROCLEAR HAYFEVER
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
149 (255 working days)
Active ingredients
Budesonide
Registration type
New generic medicine
Indication
For short-term (3-6 months) prophylaxis or treatment of seasonal allergic rhinitis (hayfever) in adults and children aged 12 years and over, and perennial allergic rhinitis in adults 18 years and over.